Professor Chantal Mathieu is Professor of Medicine and Programme Director of Biomedical Sciences at the Katholieke Universiteit Leuven, Belgium.
She is Chair of Endocrinology at the University Hospital Gasthuisberg Leuven, and has been involved in several clinical trials in type 1 and type 2 diabetes.
Her research is focused on the prevention of type 1 diabetes, effects of vitamin D on the immune system and diabetes, and functioning of the insulin-producing beta cell.
She has authored or co-authored more than 330 peer-reviewed publications in international journals and is a past associate editor and advisory board member of Diabetologia.
In 2013, Professor Mathieu received the prestigious InBev-Baillet Latour Prize for Clinical Research for her pioneering research on the pathogenesis of type 1 diabetes. She presently coordinates the INNODIA project on prevention and intervention in type 1 diabetes in Europe and will become vice-president of EASD from 1/1/2018.